| Anti-angiogenic peptides for cancer therapeutics E V Rosca, J E Koskimaki, C G Rivera, N B Pandey, A P Tamiz, A S Popel Current pharmaceutical biotechnology 12 (8), 1101-1116, 2011 | 219 | 2011 |
| Biosynthesis of luminescent quantum dots in an earthworm SR Stürzenbaum, M Höckner, A Panneerselvam, J Levitt, JS Bouillard, ... Nature Nanotechnology 8 (1), 57-60, 2013 | 191 | 2013 |
| Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 … JE Koskimaki, ED Karagiannis, EV Rosca, F Vesuna, PT Winnard Jr, ... Neoplasia 11 (12), 1285-IN2, 2009 | 85 | 2009 |
| Targeting drugs to combinations of receptors: a modeling analysis of potential specificity MR Caplan, EV Rosca Annals of biomedical engineering 33, 1113-1124, 2005 | 76 | 2005 |
| PET/PDT theranostics: synthesis and biological evaluation of a peptide-targeted gallium porphyrin F Bryden, H Savoie, EV Rosca, RW Boyle Dalton transactions 44 (11), 4925-4932, 2015 | 43 | 2015 |
| Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation E Lee, EV Rosca, NB Pandey, AS Popel The international journal of biochemistry & cell biology 43 (12), 1812-1821, 2011 | 35 | 2011 |
| Thermosensitive, near-infrared-labeled nanoparticles for topotecan delivery to tumors EV Rosca, M Wright, R Gonitel, W Gedroyc, AD Miller, M Thanou Molecular pharmaceutics 12 (5), 1335-1346, 2015 | 29 | 2015 |
| Specificity and mobility of biomacromolecular, multivalent constructs for cellular targeting EV Rosca, JM Stukel, RJ Gillies, J Vagner, MR Caplan Biomacromolecules 8 (12), 3830-3835, 2007 | 25 | 2007 |
| Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors JE Koskimaki, E Lee, W Chen, CG Rivera, EV Rosca, NB Pandey, ... Angiogenesis 16, 159-170, 2013 | 23 | 2013 |
| Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth JE Koskimaki, EV Rosca, CG Rivera, E Lee, W Chen, NB Pandey, ... Translational oncology 5 (2), 92-97, 2012 | 23 | 2012 |
| Hydrophobin-encapsulated quantum dots S Taniguchi, L Sandiford, M Cooper, EV Rosca, R Ahmad Khanbeigi, ... ACS Applied Materials & Interfaces 8 (7), 4887-4893, 2016 | 22 | 2016 |
| Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer EV Rosca, JE Koskimaki, NB Pandey, AC Wolff, AS Popel Cancer Biology & Therapy 12 (9), 808-817, 2011 | 22 | 2011 |
| Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth EV Rosca, B Lal, JE Koskimaki, AS Popel, J Laterra Anti-cancer drugs 23 (7), 706-712, 2012 | 20 | 2012 |
| Structure–Activity Relationship Study of Collagen‐Derived Anti‐Angiogenic Biomimetic Peptides EV Rosca, JE Koskimaki, NB Pandey, AP Tamiz, AS Popel Chemical biology & drug design 80 (1), 27-37, 2012 | 20 | 2012 |
| Novel peptide-specific quantitative structure–activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity CG Rivera, EV Rosca, NB Pandey, JE Koskimaki, JS Bader, AS Popel Journal of medicinal chemistry 54 (19), 6492-6500, 2011 | 19 | 2011 |
| Smart systems and the Internet of Things (IOT) for waste management CN Tamakloe, EV Rosca 2020 IEEE International Conference on Computational Intelligence and Virtual …, 2020 | 17 | 2020 |
| A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer EV Rosca, MF Penet, N Mori, JE Koskimaki, E Lee, NB Pandey, ... PloS one 9 (11), e111901, 2014 | 15 | 2014 |
| Glioblastoma targeting via integrins is concentration dependent EV Rosca, RJ Gillies, MR Caplan Biotechnology and bioengineering 104 (2), 408-417, 2009 | 11 | 2009 |
| Novel peptide-specific QSAR analysis applied to collagen IV peptides with antiangiogenic activity CG Rivera, EV Rosca, NB Pandey, JE Koskimaki, JS Bader, AS Popel Journal of medicinal chemistry 54 (19), 6492, 2011 | 9 | 2011 |
| Mimetic peptides derived from collagen type IV and their use for treating angiogenesis-and lymphagiogenesis-dependent diseases AS Popel, EV Rosca, JE Koskimaki, CG Rivera, NB Pandey, AP Tamiz US Patent 9,056,923, 2015 | 4 | 2015 |
